Green Cross Labcell acquires U.S. patent of cell therapy mass production

Published: 2017-11-27 13:40:02

Updated: 2017-11-27 13:40:02

Green Cross Labcell acquired a U.S. patent about mass production of cell therapy.

Green Cross Labcell(CEO Dae-Woo Park) announced on the 23^rd that the company acquired a patent about culture method of natural killer cells from the United States Patent and Trademark Office(USPTO).

Green Cross Labcell proved itself as a leading company in the field as acquiring patents from not only Europe and ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.